latam, life sciences, pharmaceuticals, pharma, usa, fpa, finance director
Sector: Pharmaceuticals
Hired the Head of Financial Planning & Analysis for the $3.5bn South America region of a top ten global pharmaceutical company, based out of Miami. The challenge of this role was to translate the high demands of the corporate HQ into targets for the developing, less structured countries of the south America region, working to motivate the local teams to continuously improve and seek excellence.
finance director, cfo, pharmaceuticals, otc, poland, cee, eastern europe, central europe, supply chain
Sector: Pharmaceuticals
Search mandate to recruit a country CFO for a top five pharmaceutical company. At the time Poland generated revenues of $300m and incorporated commercial, manufacturing and shared services; therefore the company was seeking a heavyweight candidate for the role. Due to the proportion of OTC sales meant the primary target was a candidate coming from FMCG instead of Pharma.
cfo, finance director, eastern europe, cis, Eurasia, emerging markets, pharmaceuticals
Sector: Pharmaceuticals
Mandate to hire the Southern Eastern Europe CFO for a top ten pharmaceutical company with regional operations in Romania, Bulgaria, Balkans as well as the CIS region, with total revenues of $250m. The tough aspect of this search was the fact the company did not have alignment internally, and started initially targeting expatriated Western Europeans, then local nationals, then "local plus".
cfo, finance director, finance director, pharmaceuticals, pharma, russia, emerging markets, Eurasia, blue chip
Sector: Pharmaceuticals
Managed the search to hire a country CFO for a highly demanding international pharmaceutical group. The Russia business generated sales of $700m and represented a huge strategic objective for the global management team. The previous Russia CFO had been highly successful so the benchmark was already very high, and intially the company sought a Western nationality candidate but the successful candidate was a Russian national.
Sector: Pharmaceuticals
A highly acquisitive global top five pharmaceutical company with operations in 100 countries. The position sits within the finance team dedicated to supporting BD&L transactions in North America and on a global basis. The Senior Finance Manager is responsible for all modelling and evaluation, supporting negotiations, working with tax and treasury on deal structuring, among other duties. Of critical importance on this search was to identify …
controller, accounting, director, Spain, pharmaceuticals, pharma, country, cluster
Sector: Pharmaceuticals
Working in partnership with a remarkable pharmaceutical company that had grown to $30 billion in revenues. The company culture is highly demanding due to the growth, the lean headcount and accountability; therefore identifying candidates who could make the transition to working in more stable companies was challenging.
The Controller is responsible for accounting, internal controls, revenues recognition, working capital and …
Sector: Consumer Healthcare
Chief Accounting Officer for a division of a leading pharmaceutical company. Controller for the $2 billion eye care division of this top ten global pharmaceuticals division.
pharmaceuticals, cfo, finance director, romania, cee, eastern europe, emerging markets
Sector: Pharmaceuticals & OTC
CFO of the combined commercial and manufacturing Romanian operations of an international pharmaceutical group. This was a challenging search in order to meet the tough demands of the company's global management team and the successful candidate was a Romanian national at the time working in London for a global FMCG company.
Sector: Pharmaceuticals
Regional Head of FP&A for the EMEA region of a US pharmaceutical company.
Sector: Pharmaceutical
CFO of the French subsidiary of a US pharmaceutical group. The listed US corp experience massive growth following the launch of a new class of product, growing to the current size of $1.5bn in the country. The challenge for this mandate was finding candidate in traditional Big Pharma companies who were capable of adjusting to the unstructured and highly dynamic pace.
